Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02575 (long intergenic non-protein coding RNA 2575) is a long non-coding RNA (lncRNA) located on human chromosome 21 and annotated as AP001065.15 in some genomic databases[1][5][7]. LINC02575 does not encode a protein but instead functions as a regulatory RNA. Experimental evidence suggests it is upregulated in laryngeal squamous cell carcinoma (LSCC) and promotes cancer cell proliferation, migration, and invasion, indicating a contributory role in tumorigenesis[4][3]. LINC02575 may serve as a prognostic biomarker or potential diagnostic indicator in certain cancers, particularly in LSCC[4][3][6]. No known drugs are reported to interact directly with LINC02575, and it is not currently used as a direct therapeutic target or classified under classical druggable gene families such as receptors or enzymes[1][5][7]. Its functional classification is best captured under 'Other,' describing its role as a regulatory non-coding RNA with emerging relevance in cancer biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on long intergenic non-protein coding RNA 2575 (LINC02575).